In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation
Annals of Internal Medicine · 2023
DOI: 10.7326/j23-0076 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Anna L Parks und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Utah, Salt Lake City, Utah, USA (A.L.P.). Hauptthemen laut MEDLINE: Fibrinolytic Agents, Pulmonary Embolism.
Abstract (Originalsprache)
SOURCE CITATION: Planer D, Yanko S, Matok I, et al. Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. CMAJ. 2023;195:E833-E843. 37336568.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Utah, Salt Lake City, Utah, USA (A.L.P.).
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah, USA (S.M.S.).
Zitieren
APA
Parks, A. L., & Stevens, S. M. (2023). In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation. Annals of Internal Medicine. https://doi.org/10.7326/j23-0076
Vancouver
Parks AL, Stevens SM. In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation. Annals of Internal Medicine. 2023. doi:10.7326/j23-0076
BibTeX
@article{Parks2023,
author = {Parks, Anna L and Stevens, Scott M},
title = {In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/j23-0076}
}
EUVIMED